Recently, Bergmann et al. [68] examined the association between the single nucleotide polymorphism rs2296308 in Rwdd3 and the development of neuropathy in paclitaxel-treated cancer patients, as was suggested by Schneider et al. [69]; however, this study was unable to confirm such a correlation. Here, RWDD3 is linked to neuropathy.